Ibrutinib is used to treat chronic lymphocytic leukemia Waldenström's macroglobulinemia, and as a second-line treatment for mantle cell lymphoma, marginal zone lymphoma, and chronic graft vs host disease. It is a small molecule drug. Reference standards of Ibrutinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => (R)-1-Boc-3-Hydroxypiperidine (BSC) [catalogue_number] => PA BSC 02709853 [category_ids] => ,169, [chemical_name] => [weight] => 201.27 [form] => C10H19NO3 [cas] => 143900-43-0 [pslug] => 143900-43-0-r-1-boc-3-hydroxypiperidine-bsc-pabsc02709853 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 02709853
CAS :
Molecular Formula : C10H19NO3
Molecular Weight : 201.27
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....